Anavex Life Sciences (AVXL)

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

O preço da ação Anavex Life Sciences Corp. Common Stock (AVXL) hoje é de $ 4,72, refletindo uma movimentação de +4,19% desde que o mercado abriu. A capitalização de mercado da empresa é de $ 438,34 mi, com um volume comercial diário de $ 903,34 mil ações. Para investidores monitorando tendências de preços, a ação Anavex Life Sciences Corp. Common Stock tem variado entre $ 4,45 e $ 4,74 hoje. O preço de fechamento anterior foi $ 4,53.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Anavex Life Sciences ações na Kraken a partir de US$ 10.